v3.26.1
Note 11 - Convertible Note Arrangement and Royalty (Details Textual)
 10 Months Ended 12 Months Ended
Oct. 29, 2025
Oct. 22, 2025
CAD ($)
$ / shares
shares
Jan. 01, 2025
Nov. 27, 2024
CAD ($)
$ / shares
shares
Nov. 27, 2024
USD ($)
$ / shares
shares
Aug. 28, 2024
Mar. 21, 2024
CAD ($)
$ / shares
shares
Mar. 21, 2024
USD ($)
shares
Feb. 27, 2024
$ / shares
Feb. 12, 2024
Jan. 15, 2024
Feb. 13, 2023
CAD ($)
shares
Oct. 22, 2025
CAD ($)
$ / shares
shares
Dec. 31, 2025
CAD ($)
$ / shares
Dec. 31, 2024
CAD ($)
Dec. 31, 2023
CAD ($)
Dec. 31, 2025
$ / shares
Oct. 22, 2025
USD ($)
$ / shares
shares
Oct. 21, 2025
USD ($)
Mar. 05, 2025
Dec. 31, 2024
$ / shares
Nov. 27, 2024
USD ($)
$ / shares
shares
Feb. 13, 2024
CAD ($)
Feb. 13, 2024
USD ($)
Jan. 31, 2024
$ / shares
Feb. 13, 2023
USD ($)
$ / shares
shares
Statement Line Items [Line Items]                                                    
Royalty payments, cumulative cap                                   $ 10,000,000 $ 6,000,000              
Increase (decrease) through conversion of interest on convertible instruments, equity                             $ 543,000 $ 795,000                    
Proceeds from borrowings, classified as financing activities                           $ 4,706,000                        
Shares issued, price per share (in dollars per share) | $ / shares                 $ 3.24                                  
Number of share options granted in share-based payment arrangement 2,669,000   125,000     250,000       753,923 25,000     2,794,000 1,028,923                      
Royalty term (Year)   7 years                     7 years         7 years 5 years              
Ordinary shares [member]                                                    
Statement Line Items [Line Items]                                                    
Increase (decrease) in number of shares outstanding, issue of equity (in shares) | shares       460,405 460,405                                          
Proceeds from issuing shares       $ 1,401,000                                            
Shares issued, price per share (in dollars per share) | $ / shares         $ 2.172                                          
Price per share purchasable by warrants (in CAD per share) | $ / shares   $ 1.25                     $ 1.25                          
The 2028 warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Class of warrants or rights, number of securities called by warrants or rights 1 (in shares) | shares                       2,699,014                           2,699,014
Warrants and rights outstanding, term 1 (Year)                       5 years                            
Class of warrant or right, exercise price (in dollars per share) | (per share)       $ 3.4                                         $ 4 $ 9.92
Class of warrant or right, acceleration clause, period (Day)       30 days 30 days                                          
Class of warrant or right, acceleration clause, stock price trigger (in CAD per share) | $ / shares       $ 3.4                                            
Class of warrant or right, threshold percentage of stock price trigger       20.00% 20.00%                                          
Class of warrant or right, acceleration clause, threshold consecutive trading days       10                                   10        
Class of warrant or right, acceleration clause, period before reduced term after trigger (Day)       7 days 7 days                                          
Number of other equity instruments outstanding in share-based payment arrangement                           0             2,699,014          
The 2027 warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Class of warrants or rights, number of securities called by warrants or rights 1 (in shares) | shares       1,136,364                                   1,136,364        
Warrants and rights outstanding, term 1 (Year)       2 years 2 years                                          
Class of warrant or right, exercise price (in dollars per share) | $ / shares       $ 4                                            
Share price (in CAD per share) | $ / shares       $ 2.72                                            
Number of other equity instruments granted in share-based payment arrangement       1,136,364 1,136,364                                          
Weighted average fair value at measurement date, other equity instruments granted       $ 1,221,000                                            
The 2027 warrants [member] | Interest rate, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities       0.032                                   0.032        
The 2027 warrants [member] | Historical volatility for shares, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities       0.70                                   0.70        
The 2027 warrants [member] | Expected dividends, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities       0                                   0        
Warrants issued on August 23, 2023 [member]                                                    
Statement Line Items [Line Items]                                                    
Class of warrant or right, exercise price (in dollars per share) | $ / shares       $ 6.84                                            
New equity offering warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Class of warrant or right, exercise price (in dollars per share) | $ / shares   $ 0.75                     $ 0.75                          
Number of other equity instruments outstanding in share-based payment arrangement                           101,041,712             0          
Number of other equity instruments granted in share-based payment arrangement                           46,000,000                        
Class of warrants or rights, shares issuable per warrant (in shares) | shares   1                     1         1                
Price per share purchasable by warrants (in CAD per share) | $ / shares   $ 1.25                     $ 1.25                          
Weighted average fair value at measurement date, other equity instruments granted   $ 79,562                     $ 79,562 $ 28,410                        
Weighted average share price, other equity instruments granted (in CAD per share) | $ / shares                         $ 2.31 $ 1.11                        
Expected volatility, other equity instruments granted                         87.00% 90.00%                        
Risk free interest rate, other equity instruments granted                         2.39% 2.81%                        
Pre-funded warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Number of other equity instruments outstanding in share-based payment arrangement                           26,405,657             0          
Number of other equity instruments granted in share-based payment arrangement                           31,735,657                        
Number of other equity instruments exercised or vested in share-based payment arrangement                           5,330,000                        
Nominal exercise price (in CAD per share) | $ / shares   $ 0.000001                     $ 0.000001                          
Weighted average fair value at measurement date, other equity instruments granted   $ 73,309,000                     $ 73,309,000 $ 29,309,000                        
New equity offering [member]                                                    
Statement Line Items [Line Items]                                                    
Number of other equity instruments granted in share-based payment arrangement   46,000,000                                                
Number of share options granted in share-based payment arrangement   46,000,000                                                
Units issued, shares issuable per unit (in shares) | shares   1                                                
The 2028 notes [member]                                                    
Statement Line Items [Line Items]                                                    
Notional amount                       $ 68,049,000                           $ 51,000,000
Borrowings, interest rate               8.99%       8.99%                           8.99%
Borrowings, covenant, percentage of royalty on operating revenue for first twelve months                       0.60%                            
Borrowings, covenant, percentage of royalty on revenue from refinery from second to fifth years                       0.60%                            
Royalty payments, cumulative cap                                                   $ 6,000,000
Increase (decrease) through conversion of interest on convertible instruments, equity             $ 543 $ 401                                    
Increase (decrease) in number of shares outstanding, conversion of interest on convertible instruments (in shares) | shares             210,760 210,760                                    
Borrowings, covenant, minimum liquidity balance                                               $ 2,000,000    
Proceeds from borrowings, classified as financing activities       $ 9,157,000 $ 6,521,000                 $ 0 $ 0 68,049,000                    
Shares issued, price per share (in dollars per share) | $ / shares             $ 2.5756                                      
Share price (in CAD per share) | $ / shares                                 $ 1.66       $ 1.807          
Borrowings, Deferred Interest Rate                                       2.25%            
Borrowings               $ 51,000,000                                    
The 2028 notes [member] | Interest rate, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities                           0.03509             0.04393          
The 2028 notes [member] | Historical volatility for shares, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities                           1.05             0.63          
The 2028 notes [member] | Credit spread, measurement input [member]                                                    
Statement Line Items [Line Items]                                                    
Significant unobservable input, liabilities                           0.274             0.263          
The 2027 notes [member]                                                    
Statement Line Items [Line Items]                                                    
Notional amount       $ 5,615,000                                   $ 4,000,000        
Borrowings, interest rate       12.00%                                   12.00%        
Borrowings, covenant, minimum liquidity balance                                           $ 2,000,000        
Proceeds from borrowings, classified as financing activities         4,000,000                 $ 0 5,498,000 0                    
Proceeds from issuing shares         $ 5,000,000                                          
Borrowings, convertible, number of equity instruments upon conversion (in shares) | shares       240,211                                   240,211        
Borrowings, convertible, principal amount denomination for conversion                                           $ 1,000        
Borrowings, convertible, conversion price (in dollars per share) | $ / shares                                           $ 2.4978        
Borrowings, Deferred Interest Rate                                       2.50%            
The 2027 notes [member] | Ordinary shares [member]                                                    
Statement Line Items [Line Items]                                                    
Increase (decrease) in number of shares outstanding, issue of equity (in shares) | shares       443,225 443,225                                          
Equity exchange [member]                                                    
Statement Line Items [Line Items]                                                    
Conversion of debt, percent of debt converted   60.00%                     60.00%         60.00%                
Conversion of debt, price per unit for conversion (in CAD per share) | $ / shares   $ 0.75                     $ 0.75                          
Equity exchange [member] | New equity offering warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Number of other equity instruments granted in share-based payment arrangement                           55,041,712                        
Equitized notes [member                                                    
Statement Line Items [Line Items]                                                    
Number of shares issued (in shares) | shares   55,041,712                     55,041,712         55,041,712                
Equitized notes [member | Ordinary shares [member]                                                    
Statement Line Items [Line Items]                                                    
Number of shares issued (in shares) | shares   23,306,055                     23,306,055         23,306,055                
Equitized notes [member | New equity offering warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Number of other equity instruments outstanding in share-based payment arrangement   55,041,712                     55,041,712         55,041,712                
Equitized notes [member | Pre-funded warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Number of other equity instruments granted in share-based payment arrangement   31,735,657                                                
Rolled notes [member]                                                    
Statement Line Items [Line Items]                                                    
Conversion of debt, percent of debt converted   40.00%                     40.00%         40.00%                
Common shares equal to principle amount, percent   12.50%                     12.50%         12.50%                
Debt exchange per share (in dollars per share) | $ / shares                                   $ 0.9                
Rolled notes [member] | Ordinary shares [member]                                                    
Statement Line Items [Line Items]                                                    
Number of shares issued (in shares) | shares   3,822,341                     3,822,341         3,822,341                
Equity exchange, conversion of 2028 and 2027 notes into equity [member]                                                    
Statement Line Items [Line Items]                                                    
Ownership of shares, percent   9.90%                                                
Term loan [member]                                                    
Statement Line Items [Line Items]                                                    
Notional amount   $ 38,902                     $ 38,902         $ 27,795                
Borrowings, interest rate   12.80%                     12.80%         12.80%                
Borrowings, covenant, minimum liquidity balance   $ 15,000,000                     $ 15,000,000                   $ 2,000,000      
Fair value of borrowing   37,258,000                     37,258,000                          
The 2028 and 2027 notes [member]                                                    
Statement Line Items [Line Items]                                                    
Fair value of borrowing   (37,258,000)                     (37,258,000)                          
Gain (loss) from extinguishment of debt before transaction costs                           $ (168,183,000)                        
The 2028 and 2027 notes [member] | New equity offering warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Weighted average fair value at measurement date, other equity instruments granted   79,562,000                     79,562,000                          
The 2028 and 2027 notes [member] | Pre-funded warrants [member]                                                    
Statement Line Items [Line Items]                                                    
Weighted average fair value at measurement date, other equity instruments granted   $ 73,309,000                     $ 73,309,000                          
Short-term bridge loan [member]                                                    
Statement Line Items [Line Items]                                                    
Borrowings, interest rate   12.00%                     12.00%         12.00%                
Proceeds from borrowings, classified as financing activities                           $ 2,784,000 $ 0 $ 0                    
Borrowings   $ 2,784,000                     $ 2,784,000         $ 2,000,000                
Repayments of current borrowings   $ 2,856,000